Writing for the Daily Express to mark the fifth anniversary of Brexit, Conservative leader Kemi Badenoch accuses Sir Keir of wanting to "tie Britain up in EU red tape, give away fishing rights and edge back to the freedom of movement of people".

Pharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in northwest England.

AstraZeneca cancels £450m vaccine plant in UK after Government 'own goal' in blow to Rachel Reeves growth plan - The pharmaceutical giant claimed the Labour Government failed to match Tory predecessor

AstraZeneca has been locked in a stand-off with the Government for months over state aid for the project, which would have involved a new factory powered by renewables built at the site. It had reportedly been offered around £90m by Rishi Sunak’s government, but Labour had sought to cut that state aid to £40m.

AstraZeneca has cancelled plans for a £450m vaccine manufacturing plant in Liverpool, blaming a cut in funding from government.

AstraZeneca’s manufacturing will-they-won’t-they within its home country has swung back firmly toward the ‘they won’t’ camp after the British pharma confirmed that it’s ditching a major venture at | AstraZeneca is pulling the plug on a 450 million pound sterling investment at its vaccine production site in England due in large part to the reduction of a planned financial contribution from the U.

In a shock move, AstraZeneca has ditched a plan to invest £450 million ($558 million) in a new vaccine manufacturing plant in the UK, after the government reduced the offer on the table to support the project.

AstraZeneca has axed plans to invest £450 million in a vaccine manufacturing plant in Merseyside in a fresh blow to Labour’s mission for growth.

AstraZeneca announced it will not proceed with plans for a 450 million pound vaccine manufacturing plant in Speke, Liverpool. The decision was influenced by discussions with the current government and changes in the financial offer.

AstraZeneca is no longer pursuing plans for a 450 million pound ($558.32 million) vaccine manufacturing plant in Speke, Liverpool, a company spokesperson said on Friday.